Renalytix plc (NASDAQ: RNLX)
$0.34
+0.0092 ( +2.79% ) 1.5M
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Market Data
Open
$0.34
Previous close
$0.33
Volume
1.5M
Market cap
$26.54M
Day range
$0.28 - $0.35
52 week range
$0.22 - $3.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 15, 2024 |
8-k/a | 8K-related | 12 | Jun 25, 2024 |
8-k | 8K-related | 11 | Jun 24, 2024 |
8-k | 8K-related | 12 | Jun 24, 2024 |
8-k | 8K-related | 13 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 12 | Jun 12, 2024 |
3 | Insider transactions | 2 | Jun 05, 2024 |
8-k | 8K-related | 13 | May 28, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |